AXL

You have access
Efficacy of Cabozantinib for Papillary Compared With Clear-cell Renal Cell Carcinoma Following Immune Checkpoint Inhibitor Treatment
HIDEKAZU TACHIBANA, TORU INAKAWA, YUKI NEMOTO, HIROKI ISHIHARA, HIRONORI FUKUDA, KAZUHIKO YOSHIDA, JUNPEI IIZUKA, YASUNOBU HASHIMOTO, KAZUNARI TANABE, TSUNENORI KONDO and TOSHIO TAKAGI

Anticancer Research June 2022, 42 (6) 3151-3158; DOI: https://doi.org/10.21873/anticanres.15804
You have access
Development of Antigen-specific Chimeric Antigen Receptor KHYG-1 Cells for Glioblastoma
CHUNG HYO KANG, YEONGRIN KIM, SO MYOUNG LEE, SANG UN CHOI and CHI HOON PARK

Anticancer Research April 2021, 41 (4) 1811-1819; DOI: https://doi.org/10.21873/anticanres.14947
You have access
AXL Downstream Targeting Unravels Synergistic Drug Combinations in Ovarian Carcinoma Cells
DESIRÈ M. ALAMPI, EMILIO CIUSANI, NIVES CARENINI, ELISABETTA CORNA, LAURA GATTI and CRISTINA CORNO

Anticancer Research July 2019, 39 (7) 3803-3808; DOI: https://doi.org/10.21873/anticanres.13529
You have access
Carvacrol Targets AXL to Inhibit Cell Proliferation and Migration in Non-small Cell Lung Cancer Cells
CHI YOUNG JUNG, SO-YOUNG KIM and CHUHEE LEE

Anticancer Research January 2018, 38 (1) 279-286;
You have access
Computational and Immunohistochemical Analyses Highlight AXL as a Potential Prognostic Marker for Ovarian Cancer Patients
LUDMILA LOZNEANU, PATRIZIA PINCIROLI, DELIA APOSTOL CIOBANU, MARIA LUISA CARCANGIU, SILVANA CANEVARI, ANTONELLA TOMASSETTI and IRINA-DRAGA CĂRUNTU

Anticancer Research August 2016, 36 (8) 4155-4163;
You have access
Activation of AXL and Antitumor Effects of a Monoclonal Antibody to AXL in Lung Adenocarcinoma
SHINYA IIDA, YASUHIRO MIKI, TAKASHI SUZUKI, KAZUSHIGE MORI, MIKIYOSHI SAITO, HIROMICHI NIIKAWA, TAKASHI KONDO, HISAFUMI YAMADA-OKABE and HIRONOBU SASANO

Anticancer Research April 2014, 34 (4) 1821-1827;

Main menu

User menu

Search

AXL